ARK THERAPEUTICS GROUP PLC
Results of General Meeting
London, UK, 11 December 2014 (LSE: AKT): Ark Therapeutics Group plc ("Ark" or the "Company") announces that at the Company's General Meeting held earlier today all resolutions were duly passed. A summary of the votes lodged by proxy is set out below:
No |
Resolution |
Votes for |
% |
Discretion |
% |
Votes against |
% |
Votes withheld |
|||||||
1 |
Proposed transfer to standard list |
73,699,781 |
92.23 |
6,189,396 |
7.75 |
15,237 |
0.02 |
38,050 |
|||||||
2 |
Adoption of 2014 Executive Option Plan |
73,692,058 |
92.25 |
6,175,245 |
7.73 |
17,609 |
0.02 |
57,552 |
|||||||
3 |
Adoption of 2014 EMI Plan |
73,692,058 |
92.25 |
6,175,245 |
7.73 |
17,609 |
0.02 |
57,552 |
|||||||
4 |
Approval of Directors' remuneration policy |
68,157,170 |
85.39 |
6,175,245 |
7.73 |
5,486,957 |
6.87 |
122,552 |
|||||||
5 |
Approval of the Rule 9 waiver |
73,703,875 |
99.74 |
175,245 |
0.24 |
17,309 |
0.02 |
46,053 |
|||||||
6 |
Approval of the Terms of the Subscription |
73,639,630 |
92.24 |
6,175,245 |
7.73 |
17,309 |
0.02 |
110,550 |
|||||||
7 |
Authority to allot shares |
73,631,243 |
92.18 |
6,233,362 |
7.80 |
17,309 |
0.02 |
60,550 |
|||||||
8 |
Disapplication of pre-emption rights |
73,627,226 |
92.16 |
6,248,362 |
7.82 |
17,309 |
0.02 |
49,567 |
|||||||
9 |
Share capital reorganisation |
73,605,664 |
92.12 |
6,233,362 |
7.80 |
65,388 |
0.08 |
38,050 |
|||||||
10 |
Amendments to Articles of Association |
73,558,743 |
92.16 |
6,248,513 |
7.82 |
17,158 |
0.02 |
88,050 |
|||||||
11 |
Name change |
73,605,664 |
92.17 |
6,233,362 |
7.81 |
15,388 |
0.02 |
88,050 |
For further information please contact:
Ark Therapeutics Group plc |
Tel: +44(0)203 755 5160 |
Iain G Ross, Non-Executive Chairman |
|
Sue Steven, Non-Executive Director |
|
You are here: news > regulatory news